| Padron, Osvaldo |
| Recruiting | 4 | 34 | US | Optilume Urethral DCB | Urotronic Inc., Laborie Medical Technologies Inc. | Urethral Stricture | 09/25 | 03/26 | | |
NCT05375903: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) |
|
|
| Recruiting | 1 | 60 | Europe, US | UGN-301, UGN-301 (zalifrelimab) intravesical solution, UGN-201, UGN-201 (imiquimod) intravesical solution, Gemcitabine | UroGen Pharma Ltd. | Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent | 12/25 | 12/25 | | |
| Recruiting | N/A | 390 | US | Active treatment, Sham | Viveve Inc. | Urinary Incontinence, Stress | 12/22 | 12/22 | | |
NCT05010759: Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer |
|
|
| Terminated | N/A | 3 | US | NanoTherm Ablation | MagForce USA | Prostate Cancer | 07/23 | 07/23 | | |
PEAK, NCT06312722: Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study |
|
|
| Recruiting | N/A | 92 | US | Optilume® BPH Catheter System | Urotronic Inc. | Benign Prostatic Hyperplasia | 02/31 | 02/31 | | |
NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System |
|
|
| Recruiting | N/A | 150 | US | Revi System Treatment, Revi System - Delayed Activation | BlueWind Medical | Urinary Urge Incontinence | 05/25 | 05/27 | | |
NCT02577302: CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology |
|
|
| Recruiting | N/A | 200 | US | CAN-Stim - Protect CAN-Stim System, SNS - InterStim® System | Uro Medical Corporation | Urinary Incontinence, Urge | 10/25 | 10/25 | | |
| Chandrasoma, Shahin |
CAPTAIN, NCT05027477: A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer |
|
|
| Recruiting | N/A | 201 | Europe, Canada, US | Radical Prostatectomy, TULSA Procedure, TULSA-PRO | Profound Medical Inc. | Prostate Cancer, Prostate Adenocarcinoma | 12/24 | 12/34 | | |
NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System |
|
|
| Recruiting | N/A | 150 | US | Revi System Treatment, Revi System - Delayed Activation | BlueWind Medical | Urinary Urge Incontinence | 05/25 | 05/27 | | |
| Sarzotti, Eryka |
NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System |
|
|
| Recruiting | N/A | 150 | US | Revi System Treatment, Revi System - Delayed Activation | BlueWind Medical | Urinary Urge Incontinence | 05/25 | 05/27 | | |
